You must be logged in to post a review.
₨ 120.00
D.Pharm
MBBS
Zominat tablet contains Zolmitriptan | belongs to 5HT1-agonist
UNLICENSED USE
Children: Treatment of acute migraine: ORAL: 12-18 yr, 2.5 mg, repeated after not less than 2 hr if migraine recurs. If response unsatisfactory after 3 attacks consider increasing dose to 5 mg or switching to alternative treatment, max 10 mg in 24 hr.
Nausea, dizziness, warm sensation, asthenia, dry mouth, somnolence, heaviness or pressure in throat, neck, limbs and chest, myalgia, muscle weakness, paraesthesia.
Adults: Initially 2.5 mg as soon as possible after the onset of attack. If symptoms persist or return, a repeat dose may be given at an interval of at least 2 hr. If the response is inadequate, increase to 5 mg doses for subsequent attacks. Recurrent attacks, max 10 mg in 24 hr. Children: Not recommended.
One of the following licensed pharmacy from the nearest location will deliver Zominat tablet 2.5 mg 3’s. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts the your request based on valid prescription and availability.
You must be logged in to post a review.
There are no questions yet. Be the first to ask a question about this product.
Internet has revolutionized the way we buy medicine, health care and sexual well being products. Online Medical Store in Pakistan – best online pharmacy in Pakistan making it possible to buy medicines online in Pakistan through home delivery using cash on delivery payment method. Online Medical Store in Pakistan- best online pharmacy in Pakistan not only allow people to buy medicine online without leaving the comfort of their homes, it also aims to deliver original medicine in Pakistan.
Products listed on medicalstore.com.pk are 100% genuine and sourced from licensed pharmacies.
We work hard to bring you unimaginable discounts without compromising on quality.
We uses SSL (standard security technology) to ensure data privacy of all our customers.
Reviews
There are no reviews yet.